Kathleen Scott - Chief Financial Officer at ARS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
SPRY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Kathleen Scott - trading volume in the past year for ARS Pharmaceuticals, Inc.

Holdings reported by Kathleen Scott for ARS Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 13.2K $211K $16.00 Aug 20, 2024 Direct
Stock Option (Right to Buy) 815K Aug 20, 2024 Direct Common Stock

Transactions reported by Kathleen Scott for ARS Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.